Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Ottawa

$105,000.00

Biomarkers in breast cancer survivors: The search for biological, physical, psychosocial, and behavioral predictors

FY 2018-19

Summary
With continued advances in detection and treatments along with the aging and growth of the population, there is an ever-increasing number of breast cancer (BC) survivors in Canada who are experiencing long-term physiological sequelae. Investigating the extend to which biomarker patterns and biopsychosocial (BPS) variables are affected by BC is important for several reasons, but most notably because these physiological post-treatment outcomes are related to survival and quality of life (QOL). To this end, the overall purpose of this research program is to examine the secretion patterns of four key biomarkers (i.e., cortisol, salivary alpha-amylase, secretory immunoglobulin A, and C-reactive protein) in BC survivors and generate novel knowledge on their BPS predictors and outcomes. Three inter-related studies will be conducted. Study 1 aims to describe secretion profiles of biomarkers in BC survivors and to compare these to women with no history of BC. Studies 2 seeks to determine whether a modifiable life factor such as physical activity can be used to counterbalance the negative physiological effects of a cancer experience. Finally, Study 3 uses a longitudinal design to assess the bi-directional associations between the physiological sequelae of BC and multiple BPS variables during the first five years post-treatment. Collectively, these studies will allow us to expand current knowledge on the late and long-term physiological impact of BC and to identify factors that can be targeted in interventions to treat and ameliorate health outcomes in the thousands of women diagnosed with BC yearly. This research is the first to compare the profiles of several biomarkers in tandem in the same BC survivors. With the number of cancer survivors climbing each year, cancer survivorship needs to be a priority in research in order to keep up with the needs of the population and efforts to better understand, monitor, and mitigate the consequences of a cancer experience is critical.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
404092
Name
Lambert Maude
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Biomarkers in breast cancer survivors: The search for biological, physical, psychosocial, and behavioral predictors
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Alpha-Amylase; Breast Cancer; C-Reactive Protein; Cortisol; Immunoglobulin A; Longitudinal; Predictors; Survivors
Abstract
With continued advances in detection and treatments along with the aging and growth of the population, there is an ever-increasing number of breast cancer (BC) survivors in Canada who are experiencing long-term physiological sequelae. Investigating the extend to which biomarker patterns and biopsychosocial (BPS) variables are affected by BC is important for several reasons, but most notably because these physiological post-treatment outcomes are related to survival and quality of life (QOL). To this end, the overall purpose of this research program is to examine the secretion patterns of four key biomarkers (i.e., cortisol, salivary alpha-amylase, secretory immunoglobulin A, and C-reactive protein) in BC survivors and generate novel knowledge on their BPS predictors and outcomes. Three inter-related studies will be conducted. Study 1 aims to describe secretion profiles of biomarkers in BC survivors and to compare these to women with no history of BC. Studies 2 seeks to determine whether a modifiable life factor such as physical activity can be used to counterbalance the negative physiological effects of a cancer experience. Finally, Study 3 uses a longitudinal design to assess the bi-directional associations between the physiological sequelae of BC and multiple BPS variables during the first five years post-treatment. Collectively, these studies will allow us to expand current knowledge on the late and long-term physiological impact of BC and to identify factors that can be targeted in interventions to treat and ameliorate health outcomes in the thousands of women diagnosed with BC yearly. This research is the first to compare the profiles of several biomarkers in tandem in the same BC survivors. With the number of cancer survivors climbing each year, cancer survivorship needs to be a priority in research in order to keep up with the needs of the population and efforts to better understand, monitor, and mitigate the consequences of a cancer experience is critical.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lambert, Maude
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~